Introducing ALTAPORE MIS System
ALTAPORE MIS System is designed to assist surgeons who want a simple, ready-to-use bone grafting system for open and minimally invasive procedures.
The system combines extended reach, controlled delivery and precise bone graft placement in a specially designed applicator with ALTAPORE Bioactive Bone Graft Substitute.
Enhanced Bone Growth
With enhanced micro and macro porosity and silicon content shown to be optimal for bone formation, ALTAPORE is designed to promote early vascularization, increase cellular activity, and enhance bone growth as demonstrated in pre-clinical and in-vitro studies.1,2,3,*
*Preclinical data. Results may not correlate to performance in humans.
Clinically Proven Fusion Rates
In a prospective, open-label, non-randomized, multicenter clinical study including 102 patients, ALTAPORE achieved successful fusion in 86.3% of patients within 12 months following Posterolateral Fusion (PLF) surgery with instrumentation.7
Additional Product Benefits
ALTAPORE achieves fusion rates on par with autograft—the gold standard in bone fusion.7,8,9*
*The fusion rate of 86.3% at month 12 with ALTAPORE Bioactive Bone Graft is an improvement in rates of 52 -80%, observed with traditional autologous iliac crest and allograft material in PLF surgery
Versatility and Ease of Use
The precise handling characteristics of ALTAPORE allow the product to be molded into multiple shapes to adapt to various surgical needs when using as standalone, with autograft, or bone marrow aspirate.1
The interconnected and open porous structure of the silicate-substituted calcium phosphate phase of ALTAPORE is similar to human cancellous bone and is designed to promote enhanced bone growth.2
INDICATIONS FOR USE
ALTAPORE is an implant intended to fill bony voids or gaps of the skeletal system (i.e., extremities, pelvis and posterolateral spine) and can be used by itself, with autograft as a bone graft extender or with autogenous bone marrow aspirate. These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure.
ALTAPORE resorbs and is replaced with bone during the healing process.
IMPORTANT RISK INFORMATION
ALTAPORE is contraindicated where the device is intended as structural/load-bearing support in the skeletal system. ALTAPORE has not been cleared for use in vertebroplasty. Attempts should not be made to modify the size of the granules or to change their shape. It is important to maximize contact between existing bone and the implant to ensure proper bone regeneration.
The effect of mixing ALTAPORE Bioactive Bone Graft with substances other than bone marrow aspirate or autologous bone is unknown.
Rx Only. For safe and proper use please refer to full device Instructions for Use for Contraindications, Warnings, and Precautions.
ALTAPORE Full Instructions for Use
ALTAPORE SHAPE Instructions for Use